US Senate backing for Canadian imports
October 29, 2003The US Senate has backed a limited scheme to allow the parallel importation of drugs from Canada in order to …
First new HIV drug in seven years gets approval
October 29, 2003The first novel HIV treatment in seven years, Roche Fuzeon, is to undergo fast track approval in the US.Fuzeon was …
New ministerial team unveiled at Department of Health
October 29, 2003The Government has used the unexpected departure of Alan Milburn to bring in four new ministers to head the Department …
Doctors shutting out sales reps
October 29, 2003Doctors are making a conscious decision to give up less of their time to see sales reps, according to a …
NHS targets to flourish under ‘arch moderniser
October 29, 2003New Health Secretary Dr John Reid has committed the NHS to continued reform despite a growing chorus of disapproval over …
AZ settles $355m fraud case
October 29, 2003AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total …
Department of Health takes a dose of its own medicine
October 29, 2003The Department of Health is to open itself up to the same adical transformationit is overseeing in the NHS by …
Final battle for future of US healthcare draws near
October 29, 2003The future of the US healthcare system and how patients pay for their medicines will be decided in the coming …
Pfizer cool on Prilosec OTC launch
October 29, 2003Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve …
Biotech consolidation picks up with $6.4bn deal
October 29, 2003The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …
Foundation status reform not most important, say trusts
October 29, 2003The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …
Novartis buys Pfizer incontinence drug
October 29, 2003Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …
Look closer – The importance of local opinion leaders
October 29, 2003Sales and Marketing key opinion leaders
There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
